focus -WSS

focus

author：focus 2025-08-31 02:03:08 - browse：574

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Ethical issues complicate the benefits of medical crowdfunding

WSS

Peter Marks talks Operation Warp Speed for Rare Diseases

Listen: Biogen's potential pivot, & Illumina's next chapter

How generative AI is inspiring dreams of a health data revolution

What American doctors can learn from their Israeli counterparts

'Make People Better': The CRISPR babies story you probably don't know

Cancer cells are shown to suck energy source from immune cells

explore

focus

Sign up for D.C. Diagnosis

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

How to protect patients from sexual assault

Hollywood unions extend contract negotiations for actors

Listen: Biogen's potential pivot, & Illumina's next chapter

As demand for Covid shots wanes, Moderna seeks its next success

Weighted lottery helped low

Dobbs anniversary: the lost opportunity of abortion as health care

Weighted lottery helped low

In age of alternative facts, a scholarly course on calling out crap

A fraught question for the kids of Alzheimer’s: Is it coming for us?

leisure time

Medicaid rebukes states for mistakenly disenrolling children

How to protect patients from sexual assault

Amazon on where the company's health care bets are headed next

Massive project maps cells in human brain in unprecedented detail

How should state employee insurance handle Wegovy?

Life sciences deals on track to hit lowest point since 2017

knowledge

entertainment

focus

explore